Page last updated: 2024-09-03

ginsenoside rh2 and 25-methoxydammarane-3,12,20-triol

ginsenoside rh2 has been researched along with 25-methoxydammarane-3,12,20-triol in 1 studies

Compound Research Comparison

Studies
(ginsenoside rh2)
Trials
(ginsenoside rh2)
Recent Studies (post-2010)
(ginsenoside rh2)
Studies
(25-methoxydammarane-3,12,20-triol)
Trials
(25-methoxydammarane-3,12,20-triol)
Recent Studies (post-2010) (25-methoxydammarane-3,12,20-triol)
29512001105

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hill, DL; Rayburn, ER; Wang, H; Wang, W; Zhang, R; Zhao, Y1

Other Studies

1 other study(ies) available for ginsenoside rh2 and 25-methoxydammarane-3,12,20-triol

ArticleYear
20(S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action.
    British journal of cancer, 2008, Feb-26, Volume: 98, Issue:4

    Topics: Animals; Apoptosis; Biomarkers, Tumor; Cell Cycle; Cell Proliferation; Drugs, Chinese Herbal; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; In Vitro Techniques; Male; Mice; Mice, Nude; Prostate-Specific Antigen; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sapogenins; Survival Rate; Triterpenes; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2008